Special Edition: PLTR — The Widest Spread on Wall Street

Nine Beats in a Row, and Still No Consensus

Monday night, Palantir Technologies did what it has now done nine consecutive quarters running: it beat consensus, by a wide margin, on both lines.

Revenue for Q2 2026 came in at $1.94 billion, up 93% year-on-year against a $1.81 billion estimate. Adjusted earnings per share hit $0.41 against a Street estimate of $0.35 — an 18.5% beat, stacked on top of a 93% top-line growth rate that would be remarkable at half this size. Net income reached $1.06 billion, more than triple the $329 million the company earned in the same quarter last year.

CEO Alex Karp’s response, delivered live on CNBC minutes after the print: “Forget consensus.”

It is a memorable line. It is also directionally correct — though not quite in the way management intended. Wall Street genuinely cannot agree on what Palantir is worth, and the size of that disagreement is now the more interesting story than the growth rate itself.

The Print, In Full

Numbers worth anchoring on, Q2 2026:

• Revenue: $1.94 billion, up 93% YoY, up 19% sequentially
• US revenue: $1.573 billion, up 115% YoY — now more than 81% of total revenue
• US commercial revenue: $764 million, up 149% YoY, up 28% sequentially
• US government revenue: $809 million, up 90% YoY
• Adjusted operating margin: 62% (GAAP operating margin: 47%)
• Net dollar retention: 157%
• Free cash flow margin: 63% — an all-time high
• Rule of 40 score: 155% (93% growth + 62% margin)
• Remaining US commercial deal value: $6.24 billion, more than double a year ago

Management didn’t just beat — they raised, for the fourth consecutive quarter. Full-year 2026 revenue guidance moved to $8.15–8.16 billion (82% growth), with US commercial revenue now guided to exceed $3.42 billion — at least 134% growth. Adjusted free cash flow guidance climbed to $4.50–4.70 billion.

Shares surged as much as 12–15% in after-hours and pre-market trading following the print — an immediate, violent market verdict that this was, unambiguously, a good quarter.

Here’s the part that should give every investor pause: shares were still down roughly 29% year-to-date heading into that print. A company growing revenue at 93%, expanding margins, and raising guidance quarter after quarter had lost nearly a third of its market value in seven months — before Monday’s numbers clawed back a chunk of that.

That’s not a normal pattern. That’s a market arguing with itself.

The Spread

Here’s where it gets genuinely strange, and where most coverage of this stock misses the real story.